We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Compex Technologies, a company specializing in the design and manufacture of
electrical muscle stimulation (EMS) products used for sports performance enhancement,
rehabilitation and pain management, announced that its Rehabilicare division
has received FDA clearance of its IF 3WAVE interferential device.
Roche Diagnostics announced that it has received FDA 510(k) clearance for the
Accu-Chek Aviva meter, its newest blood glucose meter for the management of
diabetes.
Possis Medical announced that the FDA has given clearance for its new 6 French
DVX peripheral catheter to be labeled for breaking apart and removing thrombus
from leg arteries greater than or equal to 3 mm in diameter.
Johnson & Johnson (J&J) received approval from the Federal Trade Commission
(FTC) to acquire Closure Medical, a maker of wound healing products such as
Dermabond skin adhesives.
Hypertension Diagnostics announced that on April 29 it completed the issuance
of 2,756,609 shares of common stock and 173,335 shares of Series A Convertible
preferred stock to holders of warrants to purchase common stock and preferred
stock, resulting in gross proceeds of $822,227, which represents 91 percent
of the total warrant proceeds available for exercise.
Roche Diagnostics announced the appointment of Tiffany Olson as its new head
of North America for Roche Diagnostics, and president and chief executive officer
(CEO) of Roche Diagnostics of Indianapolis, Ind. Olson will begin her responsibilities,
effective June 1.
The FDA and Kingswood Laboratories have notified healthcare professionals via
letter of a nationwide recall of Moi-Stir oral swabsticks, due to the detection
of molds (including Aspergillus and Penicillium) in certain lots, according
to an alert sent from MedWatch, the FDA's safety information and adverse event
reporting system.